Refine Search
(4)
(6)
(6)
(6)

Respiratory Diseases

Globally, at least 2 billion people are exposed to the toxic smoke of biomass fuel, typically burned inefficiently in poorly ventilated indoor stoves or fire places. One billion people inhale polluted outdoor air, and 1 billion are exposed to tobacco smoke. An estimated 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD) and about 334 million people suffer from asthma globally.

Cystic Fibrosis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cystic Fibrosis - Pipeline Review, H2 2018’, provides an overview of the Cystic Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cystic Fibrosi...

Bronchitis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bronchitis - Pipeline Review, H2 2018’, provides an overview of the Bronchitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bronchitis, complete wit...

Cough - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cough - Pipeline Review, H2 2018’, provides an overview of the Cough pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by s...

Bronchopulmonary Dysplasia - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bronchopulmonary Dysplasia - Pipeline Review, H2 2018’, provides an overview of the Bronchopulmonary Dysplasia pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Asthma - Pipeline Review, H1 2018

  • $2,500
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2018’, provides an overview of the Asthma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis b...

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2018’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

The report provides comprehensive informatio...